Source:http://linkedlifedata.com/resource/pubmed/id/19760769
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-10
|
pubmed:abstractText |
Even though p16(INK4a) (p16) immunocytochemistry has proven a useful accessory tool verifying the identification of atypical squamous cells of undetermined significance (ASC-US) categorized smears, the procedure still has limitations. To date few studies examining the usefulness of p16 immunocytochemistry in atypical squamous cells which cannot exclude HSIL (ASC-H), compared with ASC-US in liquid-based cervical smears. Therefore, we examined the correlation of p16 immunocytochemical staining with follow-up biopsy results on ASC-H categorized smears and compared the data with those classified as ASC-US on 105 liquid-based cytology samples. We found no statistical significance in the p16 expression of ASC-US smears and the presence of squamous intraepithelial lesions (SIL) in follow-up biopsies (p = 0.546). However, p16 expression did significantly correlate with the presence of SIL (p = 0.002) in ASC-H smears. There was a statistically significant relationship between p16 expression and presence of high grade squamous intraepithelial lesions (HSIL) or more on the follow-up biopsies in both ASC-US (p = 0.012) and ASC-H (p < 0.001) categorized smears. In ASC-US categorized smears, there was no statistical significance between p16 expression and the HR-HPV viral load (p = 0.091). But there was a statistical significance between p16 expression and the HR-HPV viral load (p < 0.001) in ASC-H categorized smears. Our results indicate that p16 immunostaining is a much better useful marker for HR-HPV infection and detection of SIL in ASC-H categorized smears compared to those defined as ASC-US.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1097-0339
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
168-71
|
pubmed:meshHeading |
pubmed-meshheading:19760769-Carcinoma, Squamous Cell,
pubmed-meshheading:19760769-Cervical Intraepithelial Neoplasia,
pubmed-meshheading:19760769-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:19760769-DNA, Viral,
pubmed-meshheading:19760769-Diagnosis, Differential,
pubmed-meshheading:19760769-Female,
pubmed-meshheading:19760769-Humans,
pubmed-meshheading:19760769-Immunohistochemistry,
pubmed-meshheading:19760769-Papillomaviridae,
pubmed-meshheading:19760769-Papillomavirus Infections,
pubmed-meshheading:19760769-Tumor Markers, Biological,
pubmed-meshheading:19760769-Tumor Virus Infections,
pubmed-meshheading:19760769-Uterine Cervical Neoplasms,
pubmed-meshheading:19760769-Vaginal Smears,
pubmed-meshheading:19760769-Viral Load
|
pubmed:year |
2010
|
pubmed:articleTitle |
The use of p16(INK4A) immunocytochemistry in "Atypical squamous cells which cannot exclude HSIL" compared with "Atypical squamous cells of undetermined significance" in liquid-based cervical smears.
|
pubmed:affiliation |
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|